These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 9772205)
41. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs. Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500 [TBL] [Abstract][Full Text] [Related]
42. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase]. Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616 [TBL] [Abstract][Full Text] [Related]
43. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia. Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486 [TBL] [Abstract][Full Text] [Related]
44. Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats. Obayashi H; Nezu Y; Yokota H; Kiyosawa N; Mori K; Maeda N; Tani Y; Manabe S; Sanbuissho A J Toxicol Sci; 2011 Aug; 36(4):445-52. PubMed ID: 21804308 [TBL] [Abstract][Full Text] [Related]
45. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549 [TBL] [Abstract][Full Text] [Related]
46. An experimental model of mitochondrial myopathy: germanium-induced myopathy and coenzyme Q10 administration. Wu CM; Matsuoka T; Takemitsu M; Goto Y; Nonaka I Muscle Nerve; 1992 Nov; 15(11):1258-64. PubMed ID: 1488063 [TBL] [Abstract][Full Text] [Related]
48. Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats. Itagaki M; Takaguri A; Kano S; Kaneta S; Ichihara K; Satoh K J Pharmacol Sci; 2009 Jan; 109(1):94-101. PubMed ID: 19129682 [TBL] [Abstract][Full Text] [Related]
49. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family. Trøseid M; Henriksen OA; Lindal S APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940 [TBL] [Abstract][Full Text] [Related]
50. Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats. Ghalwash M; Elmasry A; El-Adeeb N J Basic Clin Physiol Pharmacol; 2018 Sep; 29(5):483-491. PubMed ID: 29584613 [No Abstract] [Full Text] [Related]
51. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Jacobson TA Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins. Escobales N; Crespo MJ; Altieri PI; Furilla RA J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483 [TBL] [Abstract][Full Text] [Related]
53. Histopathologic and Biochemical Evidence for Mitochondrial Disease Among 279 Patients with Severe Statin Myopathy. Hou T; Li Y; Chen W; Heffner RR; Vladutiu GD J Neuromuscul Dis; 2017; 4(1):77-87. PubMed ID: 28269789 [TBL] [Abstract][Full Text] [Related]
54. Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats. Khalil MS; Khamis N; Al-Drees A; Abdulghani HM Histol Histopathol; 2015 Mar; 30(3):383-90. PubMed ID: 25366571 [TBL] [Abstract][Full Text] [Related]
55. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells. Yamazaki H; Suzuki M; Aoki T; Morikawa S; Maejima T; Sato F; Sawanobori K; Kitahara M; Kodama T; Saito Y J Atheroscler Thromb; 2006 Dec; 13(6):295-307. PubMed ID: 17192694 [TBL] [Abstract][Full Text] [Related]
57. Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape. Ren L; Xuan L; Han F; Zhang J; Gong L; Lv Y; Zhang W; Yang S; Xu B; Yan Y; Guo L; Liu H; Wan Z; Liu L Toxicol Appl Pharmacol; 2020 Aug; 401():115076. PubMed ID: 32479918 [TBL] [Abstract][Full Text] [Related]
58. The protective effect of Herba Cistanches on statin-induced myotoxicity in vitro. Wat E; Ng CF; Koon CM; Wong EC; Tomlinson B; Lau CB J Ethnopharmacol; 2016 Aug; 190():68-73. PubMed ID: 27286913 [TBL] [Abstract][Full Text] [Related]
59. Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model. Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; MacDonald JS Eur Heart J; 1992 Jul; 13 Suppl B():2-6. PubMed ID: 1644096 [No Abstract] [Full Text] [Related]